Skip to Content
Merck
CN
All Photos(2)

Documents

MAB1580

Sigma-Aldrich

Anti-Oligodendrocytes Antibody, clone NS-1

ascites fluid, clone NS-1, Chemicon®

Sign Into View Organizational & Contract Pricing

Synonym(s):
RIP
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

biological source

mouse

Quality Level

antibody form

ascites fluid

antibody product type

primary antibodies

clone

NS-1, monoclonal

species reactivity

human, hamster, rat, mouse

manufacturer/tradename

Chemicon®

technique(s)

immunocytochemistry: suitable
immunohistochemistry: suitable

isotype

IgG

shipped in

dry ice

target post-translational modification

unmodified

Gene Information

human ... OLIG2(10215)

Specificity

Recognizes Oligodendrocytes and their myelin sheaths. MAB1580 stains both early and mature oligodendrocites.

Immunogen

Rat olfactory bulb

Application

Detect Oligodendrocytes using this Anti-Oligodendrocytes Antibody, clone NS-1 validated for use in IC, IH.
Immunohistochemistry: 1:1000-1:200,000 on 4% paraformaldehyde fixed tissue.

Immunocytochemistry

Optimal working dilutions must be determined by the end user.
Research Category
Neuroscience
Research Sub Category
Neuronal & Glial Markers

Physical form

Liquid with 0.1% sodium azide.
Unpurified

Storage and Stability

Maintain for 1 year at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Analysis Note

Control
Oligodendrocyte culture, Brain

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

WGK

nwg


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Naomi L Sayre et al.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 37(2), 514-527 (2016-02-14)
We previously demonstrated that stimulation of astrocyte mitochondrial ATP production via P2Y1 receptor agonists was neuroprotective after cerebral ischemic stroke. Another mechanism that increases ATP production is fatty acid oxidation (FAO). We show that in primary human astrocytes, FAO and
Nathan VanderVeen et al.
Human gene therapy methods, 27(3), 98-111 (2016-04-09)
Glioblastoma multiforme (GBM) is the most commonly occurring primary brain cancer in adults, in whom its highly infiltrative cells prevent total surgical resection, often leading to tumor recurrence and patient death. Our group has discovered a gene therapy approach for
Hua Jia Diao et al.
Journal of controlled release : official journal of the Controlled Release Society, 208, 85-92 (2015-03-10)
Remyelination in the central nervous system (CNS) is critical in the treatment of many neural pathological conditions. Unfortunately, the ability to direct and enhance oligodendrocyte (OL) differentiation and maturation remains limited. It is known that microenvironmental signals, such as substrate
Nowruz Najafzadeh et al.
Neural regeneration research, 8(36), 3365-3372 (2014-09-11)
Emerging studies of treating spinal cord injury (SCI) with adult stem cells led us to evaluate the effects of transplantation of hair follicle stem cells in rats with a compression-induced spinal cord lesion. Here, we proposed a hypothesis that rat
Xavier d'Anglemont de Tassigny et al.
Hypoxia (Auckland, N.Z.), 3, 15-33 (2015-06-08)
Chronic hypoxemia, as evidenced in de-acclimatized high-altitude residents or in patients with chronic obstructive respiratory disorders, is a common medical condition that can produce serious neurological alterations. However, the pathogenesis of this phenomenon is unknown. We have found that adult

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service